Explaining the Decrease in U.S. Deaths from Coronary Disease, 1980–2000
The DOI matches its Crossref record; 45 of the 45 references it cites were found in a registry or an index.
Abstract
BACKGROUND: Mortality from coronary heart disease in the United States has decreased substantially in recent decades. We conducted a study to determine how much of this decrease could be explained by the use of medical and surgical treatments as opposed to changes in cardiovascular risk factors. METHODS: We applied a previously validated statistical model, IMPACT, to data on the use and effectiveness of specific cardiac treatments and on changes in risk factors between 1980 and 2000 among U.S. adults 25 to 84 years old. The difference between the observed and expected number of deaths from coronary heart disease in 2000 was distributed among the treatments and risk factors included in the analyses. RESULTS: From 1980 through 2000, the age-adjusted death rate for coronary heart disease fell from 542.9 to 266.8 deaths per 100,000 population among men and from 263.3 to 134.4 deaths per 100,000 population among women, resulting in 341,745 fewer deaths from coronary heart disease in 2000. Approximately 47% of this decrease was attributed to treatments, including secondary preventive therapies after myocardial infarction or revascularization (11%), initial treatments for acute myocardial infarction or unstable angina (10%), treatments for heart failure (9%), revascularization for chronic angina (5%), and other therapies (12%). Approximately 44% was attributed to changes in risk factors, including reductions in total cholesterol (24%), systolic blood pressure (20%), smoking prevalence (12%), and physical inactivity (5%), although these reductions were partially offset by increases in the body-mass index and the prevalence of diabetes, which accounted for an increased number of deaths (8% and 10%, respectively). CONCLUSIONS: Approximately half the decline in U.S. deaths from coronary heart disease from 1980 through 2000 may be attributable to reductions in major risk factors and approximately half to evidence-based medical therapies.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Between 1950 and 1970 most of the decline in mortality rates from CVD was due to prevention (Goldman & Cook, 1984), whereas acute disease management and medical treatments accounted for about half of the decline between 1980 and 2000 (Ford et al., 2007).”
From Mortality and Morbidity Trends: Is There Compression of Morbidity? (2011) · cites this paper as Ford et al., 2007
In the citing paper
“Past studies show the effect of access to high-quality personal health care on both communicable and non-communicable diseases, highlighting the importance of prioritising personal health-care access and quality for all populations across the development spectrum.39–42”
In the citing paper
“Prevention works: .50% of the reductions seen in CHD mortality relate to changes in risk factors, and 40% to improved treatments.”
From European Guidelines on cardiovascular disease prevention in clinical practice (version 2012) (2012) · cites this paper as [29]
In the citing paper
“Another approach to understanding the changes in CVD mortality and incidence rates is by applying models such as the IMPACT mortality model.29 Based on information on changes in coronary risk factors and in treatment as obtained from the results of RCTs regarding the effectiveness of different treatment modalities, it estimates the expected influence on CHD mortality by age and gender.”
From European Guidelines on cardiovascular disease prevention in clinical practice (version 2012) (2012) · cites this paper as [29]
In the citing paper
“Beneficial reductions in major risk factors-in particular smoking, BP, and cholesterol-accounted for more than half of the decrease in CHD deaths, although they were counteracted by an increase in the prevalence of obesity and type 2 diabetes; 40% of the decline in CHD death rates is attributed to better treatments of acute myocardial infarction, heart failure, and other cardiac conditions.”
From European Guidelines on cardiovascular disease prevention in clinical practice (version 2012) (2012) · cites this paper as [29]
9 more claims about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
Collaboration, A. T. (2002) · BMJ · doi:10.1136/bmj.324.7329.71 · Cited by 6,943
Prevalence of Overweight and Obesity Among US Children, Adolescents, and Adults, 1999-2002
Hedley, A. A. (2004) · JAMA · doi:10.1001/jama.291.23.2847 · Cited by 4,460
Writing Group Members, Thom, T., Haase, N., Rosamond, W., Howard, V. J., Rumsfeld, J., Manolio, T., Zheng, Z.-J., Flegal, K., O’Donnell, C., et al. (2006) · Circulation · doi:10.1161/circulationaha.105.171600 · Cited by 3,451
Rosamond, W., Flegal, K., Friday, G., Furie, K., Go, A., Greenlund, K., Haase, N., Ho, M., Howard, V., Kissela, B., et al. (2007) · Circulation · doi:10.1161/circulationaha.106.179918 · Cited by 3,277
Excess Deaths Associated With Underweight, Overweight, and Obesity
Flegal, K. M. (2005) · JAMA · doi:10.1001/jama.293.15.1861 · Cited by 2,824
Harris, M. I., Flegal, K. M., Cowie, C. C., Eberhardt, M. S., Goldstein, D. E., Little, R. R., Wiedmeyer, H.-M., & Byrd-Holt, D. D. (1998) · Diabetes Care · doi:10.2337/diacare.21.4.518 · Cited by 2,703
A Potential Decline in Life Expectancy in the United States in the 21st Century
Olshansky, S. J., Passaro, D. J., Hershow, R. C., Layden, J., Carnes, B. A., Brody, J., Hayflick, L., Butler, R. N., Allison, D. B., & Ludwig, D. S. (2005) · New England Journal of Medicine · doi:10.1056/nejmsr043743 · Cited by 2,612
Hajjar, I. (2003) · JAMA · doi:10.1001/jama.290.2.199 · Cited by 2,409
A Potential Decline in Life Expectancy in the United States in the 21st Century
Olshansky, S. J., Passaro, D. J., Hershow, R. C., Layden, J., Carnes, B. A., Brody, J., Hayflick, L., Butler, R. N., Allison, D. B., & Ludwig, D. S. (2005) · Obstetrical & Gynecological Survey · doi:10.1097/01.ogx.0000167407.83915.e7 · Cited by 1,944
Burt, V. L., Cutler, J. A., Higgins, M., Horan, M. J., Labarthe, D., Whelton, P., Brown, C., & Roccella, E. J. (1995) · Hypertension · doi:10.1161/01.hyp.26.1.60 · Cited by 1,252
Self-citationLaw, M. R., Wald, N. J., & Thompson, S. G. (1994) · BMJ · doi:10.1136/bmj.308.6925.367 · Cited by 1,210
Harris, M. I., Hadden, W. C., Knowler, W. C., & Bennett, P. H. (1987) · Diabetes · doi:10.2337/diab.36.4.523 · Cited by 1,096
Critchley, J. A., & Capewell, S. (2003) · JAMA · doi:10.1001/jama.290.1.86 · Cited by 1,089
Self-citationUnal, B., Critchley, J. A., & Capewell, S. (2004) · Circulation · doi:10.1161/01.cir.0000118498.35499.b2 · Cited by 739
Self-citationHunink, M. G. M. (1997) · JAMA · doi:10.1001/jama.277.7.535 · Cited by 679
Rogers, W. J., Canto, J. G., Lambrew, C. T., Tiefenbrunn, A. J., Kinkaid, B., Shoultz, D. A., Frederick, P. D., & Every, N. (2000) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(00)00996-7 · Cited by 657
Uncertainty in the economic evaluation of health care technologies: the role of sensitivity analysis
Briggs, A., Sculpher, M., & Buxton, M. (1994) · Health Economics · doi:10.1002/hec.4730030206 · Cited by 521
Johnson, C. L. (1993) · JAMA · doi:10.1001/jama.269.23.3002 · Cited by 468
Change in the prevalence of overweight and obesity among young Australians, 1969–1997
Booth, M. L., Chey, T., Wake, M., Norton, K., Hesketh, K., Dollman, J., & Robertson, I. (2003) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/77.1.29 · Cited by 439
Changes in risk factors explain changes in mortality from ischaemic heart disease in Finland
Vartiainen, E., Puska, P., Pekkanen, J., Toumilehto, J., & Jousilahti, P. (1994) · BMJ · doi:10.1136/bmj.309.6946.23 · Cited by 438
GOLDMAN, L., & COOK, E. F. (1984) · Annals of Internal Medicine · doi:10.7326/0003-4819-101-6-825 · Cited by 381
Ford, E. S., Mokdad, A. H., Giles, W. H., & Mensah, G. A. (2003) · Circulation · doi:10.1161/01.cir.0000066320.27195.b4 · Cited by 357
Self-citationExplaining the Decline in Coronary Heart Disease Mortality in Finland between 1982 and 1997
Laatikainen, T., Critchley, J., Vartiainen, E., Salomaa, V., Ketonen, M., & Capewell, S. (2005) · American Journal of Epidemiology · doi:10.1093/aje/kwi274 · Cited by 331
Self-citationCapewell, S., Morrison, C. E., & McMurray, J. J. (1999) · Heart · doi:10.1136/hrt.81.4.380 · Cited by 308
Self-citationMokdad, A. H., Stroup, D. F., & Giles, W. H. (2003) · PubMed · Cited by 308
Self-citationExplaining the Increase in Coronary Heart Disease Mortality in Beijing Between 1984 and 1999
Critchley, J., Liu, J., Zhao, D., Wei, W., & Capewell, S. (2004) · Circulation · doi:10.1161/01.cir.0000140668.91896.ae · Cited by 304
Self-citationMant, J., & Hicks, N. (1995) · BMJ · doi:10.1136/bmj.311.7008.793 · Cited by 303
Unal, B., Critchley, J. A., & Capewell, S. (2005) · BMJ · doi:10.1136/bmj.38561.633345.8f · Cited by 293
Self-citationHarris, M. I., Hadden, W. C., Knowler, W. C., et al. (1987) · Diabetes · doi:10.2337/diabetes.36.4.523 · Cited by 288
Rose, K. M., Eigenbrodt, M. L., Biga, R. L., Couper, D. J., Light, K. C., Sharrett, A. R., & Heiss, G. (2006) · Circulation · doi:10.1161/circulationaha.105.598722 · Cited by 287
Capewell, S., Beaglehole, R., Seddon, M., & McMurray, J. (2000) · Circulation · doi:10.1161/01.cir.102.13.1511 · Cited by 253
Self-citationOutpatient adherence to beta-blocker therapy after acute myocardial infarction
Butler, J., Arbogast, P. G., BeLue, R., Daugherty, J., Jain, M. K., Ray, W. A., & Griffin, M. R. (2002) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(02)02379-3 · Cited by 162
Hippisley‐Cox, J., & Coupland, C. A. C. (2005) · BMJ · doi:10.1136/bmj.330.7499.1059 · Cited by 142
Trends in case-fatality in 117718 patients admitted with acute myocardial infarction in Scotland
Capewell, S., Livingston, B. M., MacIntyre, K., Chalmers, J. W., Boyd, J., Finlayson, A., Redpath, A., Pell, J. P., Evans, C. J., & McMurray, J. J. (2000) · European Heart Journal · doi:10.1053/euhj.2000.2318 · Cited by 123
Self-citationA Critical Evaluation of the Methodology of the Literature on Medication Compliance
Nichol, M. B., Venturini, F., & Sung, J. (1999) · Annals of Pharmacotherapy · doi:10.1345/aph.18233 · Cited by 114
Medical management and the decline in mortality from coronary heart disease.
Beaglehole, R. (1986) · BMJ · doi:10.1136/bmj.292.6512.33 · Cited by 94
Ünal, B., Critchley, J., Fidan, D., & Capewell, S. (2005) · American Journal of Public Health · doi:10.2105/ajph.2003.029579 · Cited by 93
Self-citationBots, M. L., & Grobbee, D. E. (1996) · European Journal of Cardiovascular Prevention & Rehabilitation · doi:10.1177/174182679600300302 · Cited by 76
Bots, M. L., & Grobbee, D. E. (1996) · Journal of Cardiovascular Risk · doi:10.1097/00043798-199606000-00002 · Cited by 55
The Development of a Simulation Model of the Treatment of Coronary Heart Disease
Cooper, K., Davies, R., Roderick, P., Chase, D., & Raftery, J. (2002) · Health Care Management Science · doi:10.1023/a:1020378022303 · Cited by 53
McAlister, F. A. (2002) · International Journal of Epidemiology · doi:10.1093/ije/31.1.76 · Cited by 52
Doliszny, K. M., Luepker, R. V., Burke, G. L., Pryor, D. B., & Blackburn, H. (1994) · Journal of the American College of Cardiology · doi:10.1016/0735-1097(94)90547-9 · Cited by 29
Hippisley‐Cox, J., & Coupland, C. A. C. (2005) · ACC Current Journal Review · doi:10.1016/j.accreview.2005.08.006 · Cited by 4
Research works printed but not linked: 3
- 2004, MMWR Morb Mortal Wkly Rep, 53, 82
- Ryan R, 2001, Health Stat Q, 12, 34
- Mokdad AH, 2003, MMWR Recomm Rep, 52, 1
Cited by
James, S. L., Abate, D., Abate, K. H., Abay, S. M., Abbafati, C., Abbasi, N., Abbastabar, H., Abd-Allah, F., Abdela, J., Abdelalim, A., et al. (2018) · The Lancet · doi:10.1016/s0140-6736(18)32279-7 · Cited by 13,867
Vos, T., Abajobir, A. A., Abate, K. H., Abbafati, C., Abbas, K. M., Abd-Allah, F., Abdulkader, R. S., Abdulle, A. M., Abebo, T. A., Abera, S. F., et al. (2017) · The Lancet · doi:10.1016/s0140-6736(17)32154-2 · Cited by 13,220
Heart Disease and Stroke Statistics—2017 Update: A Report From the American Heart Association
Benjamin, E. J., Blaha, M. J., Chiuve, S. E., Cushman, M., Das, S. R., Deo, R., de Ferranti, S. D., Floyd, J., Fornage, M., Gillespie, C., et al. (2017) · Circulation · doi:10.1161/cir.0000000000000485 · Cited by 12,591
Heart Disease and Stroke Statistics—2019 Update: A Report From the American Heart Association
Benjamin, E. J., Muntner, P., Alonso, A., Bittencourt, M. S., Callaway, C. W., Carson, A. P., Chamberlain, A. M., Chang, A. R., Cheng, S., Das, S. R., et al. (2019) · Circulation · doi:10.1161/cir.0000000000000659 · Cited by 9,036
European Guidelines on cardiovascular disease prevention in clinical practice (version 2012)
Authors/Task Force Members:, Perk, J., De Backer, G., Gohlke, H., Graham, I., Reiner, Ž., Verschuren, M., Albus, C., Benlian, P., Boysen, G., et al. (2012) · European Heart Journal · doi:10.1093/eurheartj/ehs092 · Cited by 8,490
Metadata
- Authors
- Ford, E. S., Ajani, U. A., Croft, J. B., Critchley, J. A., Labarthe, D. R., Kottke, T. E., Giles, W. H., & Capewell, S.
- Affiliations
- Centers for Disease Control and Prevention (US)
- Newcastle University (GB)
- HealthPartners (US)
- University of Liverpool (GB)
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 2007-06-07
- Volume
- 356
- Issue
- 23
- Pages
- 2388-2398
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- OpenAlex
- W2150278133
- Cited by
- 2,757
- References
- 44
- Citations by year
- 2026: 56 · 2025: 66 · 2024: 60 · 2023: 82 · 2022: 100 · 2021: 101 · 2020: 114 · 2019: 129 · 2018: 129 · 2017: 153 · 2016: 163 · 2015: 209 · 2014: 173 · 2013: 198 · 2012: 252
- FWCI
- 127.32
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- New England Journal of Medicine (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Epidemiology › Healthcare Systems and Public Health
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiovascular Health and Risk Factors
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Health Promotion and Cardiovascular Prevention
- Keywords
- coronary heart disease mortality, mortality decline, cardiovascular risk factors, IMPACT model, secondary prevention after myocardial infarction, revascularization, acute myocardial infarction treatment, unstable angina, heart failure treatment, cholesterol lowering, blood pressure reduction, smoking, physical inactivity, body mass index, diabetes mellitus, sex differences in mortality
- MeSH terms
- Adult, Aged, Aged, 80 and over, Coronary Disease, Female, Humans, Male, Middle Aged, Mortality, Myocardial Infarction, Myocardial Revascularization, Risk Factors, United States
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.